Background Ocular trauma is a relevant cause of monoocular blindness in Africa. Although once neglected, it has recently been incriminated as one of the main etiologies of non-congenital visual impairment throughout Africa, the epidemiology of ocular injuries varies across regions, and remains an increasing concern, hence the interest in highlighting its aspects.

Objective This study aims to take stock of the overall situation on the epidemio-clinical, etiological and therapeutic aspects.

Methods This study is a narrative literature review of articles on ocular trauma in Africa published in Medline via Pubmed and Semantic scholar from Research rabbit. After cross-referencing the keywords, we found, relative to our study period from 2012 to 2022, 215 articles in the literature on eye trauma, of which nine articles were thus retained according to the inclusion and exclusion criteria.

Results In relation to the frequency, the highest frequency according to the regions is 44.1% observed in the studies carried out in Tanzania in 2019 and the lowest is observed in the studies carried out in Nigeria in 2017 while two years later still in Nigeria the results showed an increasing trend to 30.7%; which proves that the frequency of eye trauma in Africa varies in time and space. Clinically, the results illustrate the most common clinical signs. It emerges that each study has its particularity on the most common signs. Whatever the spatio-temporal particularities of eye trauma, the most commonly used management is medical treatment.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript